Boardroom Alpha
Meeting calendar
KD · Annual meeting · Thursday, July 30, 2026

Kyndryl Holdings Inc

6 nominees · 4 ballot items.

Election of six directors; advisory (non-binding) approval of executive compensation (Say-on-Pay); approval of the Amended and Restated Kyndryl 2021 Long-Term Performance Plan (increase equity share reserve); and ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal 2027.

Market cap
$3.2B
1Y TSR
-56.5%
Board grade
B
Record date
Jun 3, 2026
Filing
DEF 14A
Meeting concluded · Jul 30, 2026

Follow how the vote landed and what changed on Kyndryl Holdings Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect six director nominees (John D. Harris II, Janina Kugel, Denis Machuel, Rahul N. Merchant, Jana Schreuder and Howard I. Ungerleider) to serve one-year terms.

  2. 2

    Advisory Vote to Approve Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding, advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the Proxy Statement.

    More detail

    This non-binding advisory proposal requests stockholder approval of the Company’s disclosed executive compensation (Say-on-Pay). Management is asking shareholders to affirm its compensation decisions, which are intended to align pay with performance and stockholder interests through a mix of performance-based annual bonuses and long-term equity incentives (PSUs and RSUs). The Compensation and Human Capital Committee revised long-term incentive design in fiscal 2026 to emphasize adjusted operating cash flow with a relative TSR modifier and increased maximum PSU payout to strengthen long-term alignment. The CHC Committee also made targeted adjustments to CEO pay to reflect post-Spin scale and retention considerations, while maintaining a high percentage of at-risk compensation. The Board emphasizes that the vote is advisory but will be taken into account in future compensation decisions; high prior-year support (97% in 2025) and ongoing investor engagement informed management’s approach. A FOR recommendation reflects the Board’s view that the programs appropriately balance retention, pay-for-performance, risk mitigation (clawbacks, minimum vesting, no single-trigger CIC vesting), and alignment with stockholders. Because the vote is non-binding, the Board retains discretion over compensation design and will consider stockholder feedback alongside performance and market data when making future changes.

  3. 3

    Approval of the Amended and Restated Kyndryl 2021 Long-Term Performance Plan

    ManagementBoard: FOR

    Approve amendment and restatement of the Company’s long-term equity incentive plan to increase the shares authorized for issuance (proposed increase of 7,600,000 shares) and adopt the plan’s other terms.

    More detail

    This proposal asks shareholders to approve an amended and restated version of Kyndryl’s long-term incentive plan that would increase the share reserve by 7,600,000 shares and modernize plan terms. Management seeks approval to preserve the Company’s ability to grant equity awards (PSUs, RSUs, options, SARs and other awards) used for aligning executive and employee interests with long-term stockholder value and for retention. The filing notes that without approval the Company would eventually exhaust available shares and be forced to rely more heavily on cash compensation, which could increase cash outflows and weaken alignment between employees and stockholders. The Plan includes multiple stockholder-protective features — independent Committee administration, a one-year minimum vesting requirement (with limited exceptions), no evergreen automatic increases, limits on director compensation, prohibition on repricing without stockholder approval, dividend-equivalent restrictions, and clawback provisions — that management highlights to mitigate dilution and governance risk. The proxy also provides dilution and equity plan metrics (including current outstanding awards, shares available and projected dilution if approved) and explains administrative mechanics, change-in-control treatment, substitute awards, and Section 409A and 162(m) considerations. The Board’s FOR recommendation reflects the view that the Plan is necessary to execute compensation strategy, maintain competitive pay practices, and preserve retention and incentive tools while incorporating governance safeguards; rejection could materially hamper the Company’s ability to grant equity incentives and retain talent.

  4. 4

    Ratification of the Appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for Fiscal 2027

    ManagementBoard: FOR

    Ratify the Audit Committee’s selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal 2027.

Director elections

Nominees on the ballot6

Independent
Tenure on this board
5.0 yrs
Also a director at
Flex Ltd (FLEX)Cisco Systems Inc (CSCO)Exxon Mobil Corp (XOM)
Independent
Tenure on this board
5.0 yrs
Also a director at
Bank Of Nt Butterfield & Son Ltd (NTB)
Independent
Tenure on this board
5.0 yrs
Also a director at
American Airlines Group Inc (AAL)Air Products & Chemicals Inc (APD)Phillips 66 (PSX)
Ownership

Top institutional holders10

Latest 13F quarter
1VANGUARD PORTFOLIO MANAGEMENT LLC7.7%16,681,449$189M
2AQR CAPITAL MANAGEMENT LLC6.7%14,580,079$159M
3BlackRock, Inc.5.9%12,915,874$146M
4Neuberger Berman Group LLC5.0%10,804,628$122M
5VANGUARD CAPITAL MANAGEMENT LLC4.7%10,197,748$115M
6STATE STREET CORP3.6%7,792,865$88M
7D. E. Shaw & Co., Inc.Activist3.4%7,339,710$83M
8BlackRock, Inc.3.1%6,680,096$76M
9FMR LLC2.8%6,116,638$69M
10GEODE CAPITAL MANAGEMENT, LLC1.7%3,689,193$43M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Kyndryl Holdings Inc 2026 annual meeting?
Kyndryl Holdings Inc (KD) holds its 2026 annual shareholder meeting on Thursday, July 30, 2026.
What is the record date for the Kyndryl Holdings Inc 2026 meeting?
The record date for the Kyndryl Holdings Inc 2026 meeting is Wednesday, June 3, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Kyndryl Holdings Inc's 2026 meeting?
The board is presenting 6 director nominees at the Kyndryl Holdings Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Kyndryl Holdings Inc 2026 meeting?
Shareholders will vote on 4 proposals at the Kyndryl Holdings Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer